Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
27 studies found for:    " December 17, 2008":" January 16, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" December 17, 2008":" January 16, 2009"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Completed Pilot Study of a Raltegravir Based NRTI Sparing Regimen
Conditions: Acquired Immune Deficiency Syndrome;   AIDS;   Human Immunodeficiency Virus;   HIV Infections
Interventions: Drug: Raltegravir;   Drug: Atazanavir;   Other: Standard treatment regimen
2 Completed Safety of the HIV Vaccine 732461 in HIV Infected Subjects Aged 18 to 55 Years Old
Condition: HIV (Human Immunodeficiency Virus)-Infected Adults
Interventions: Biological: HIV Vaccine 732461;   Biological: Placebo vaccine
3 Completed Investigation Of Safety And Pharmacokinetics Following A Single Oral Dose Of 300 Mg Maraviroc In Healthy Male Japanese Volunteers
Condition: Human Immunodeficiency Virus (HIV) Infection
Intervention: Drug: maraviroc (Selzentry, Celsentri)
4 Unknown  Effective Aids Treatment and Support in the Free State (FEATS)
Conditions: HIV/AIDS;   Food Insecurity;   HIV Infections
Interventions: Behavioral: ARV peer adherence support (PAS);   Dietary Supplement: Nutritional support;   Drug: ARV treatment
5 Unknown  Alveolar Macrophage Proteomics in HIV-associated Emphysema
Conditions: HIV;   Emphysema;   HIV Infections
Intervention:
6 Completed Safety of and Immune Response to a Prime-Boost Vaccine Regimen in HIV-Uninfected Vaccine-Naive Adults
Condition: HIV Infections
Interventions: Biological: DNA Vaccine;   Biological: Placebo;   Biological: rMVA vaccine
7 Recruiting The Use of a Distress Thermometer in a Pediatric Research Setting: An Exploratory Pilot Study
Conditions: Cancer;   HIV Infections
Intervention:
8 Completed Evaluation of Alternative Antimalarial Drugs for Malaria in Pregnancy
Conditions: Pregnancy;   Malaria;   HIV Infections
Interventions: Drug: Sulphadoxine-pyrimethamine;   Drug: Mefloquine (full dose);   Drug: Mefloquine (split dose);   Drug: placebo;   Drug: mefloquine
9 Completed Renal Function Assessment in HIV Patient
Conditions: Chronic Kidney Disease;   HIV Infections
Intervention: Other: DEXA scan
10 Completed Efficacy and Safety of 2 Raltegravir Doses in Naive HIV-1-infected Patients Receiving Rifampin for Active Tuberculosis
Conditions: HIV Infections;   Tuberculosis
Interventions: Drug: efavirenz;   Drug: raltegravir
11 Terminated
Has Results
A Rollover Study For Subjects Discontinuing From UK-453,061 Studies For The Treatment Of HIV-1
Condition: HIV-1
Intervention: Drug: No drug will be administered
12 Completed
Has Results
A Study Of Different Doses Of UK-453, 061 Plus Truvada Compared To Efavirenz Plus Truvada In Patients Who Have Not Been Previously Treated For HIV-1
Condition: HIV-1
Interventions: Drug: UK-453, 061;   Drug: EFV +TVA
13 Completed Beta-2 Microglobulin and Serum Cytokines x HAART
Condition: HIV Patients
Intervention:
14 Completed Interactions Between Antiretrovirals (ARVs) and Combined Oral Contraceptives (COCs)
Conditions: HIV/AIDS;   HIV Infections
Intervention: Drug: ETHINYL ESTRADIOL AND LEVOGESTREL
15 Completed TMC278-TiDP38-C145: A Bioavailability Study in Healthy Adult Volunteers to Evaluate 3 Pediatric Formulations of TMC278 (a Solution, a Suspension, and Granules) Compared to an Adult Tablet Formulation
Conditions: Pharmacokinetics;   Bioavailability;   HIV-1
Intervention: Drug: TMC278
16 Terminated Can Presumptive Anthelminthic Treatment Delay the Progression of HIV in ART-naïve Patients in Rural Africa?
Conditions: HIV Infections;   Helminthiasis
Intervention: Drug: Praziquantel, Ivermectin, Albendazole
17 Terminated
Has Results
A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1
Condition: HIV-1
Interventions: Drug: UK-453,061 Dose 1;   Drug: UK-453,061 Dose 2;   Drug: Etravirine
18 Completed Pharmacokinetic Study of Posaconazole Boosted Fosamprenavir
Conditions: HIV Infection;   Fungal Infection
Interventions: Drug: Posaconazole;   Drug: Fosamprenavir;   Drug: Ritonavir
19 Completed
Has Results
Comparative Study of Three NNRTI-Sparing HAART Regimens
Condition: HIV Infection
Interventions: Drug: Emtricitabine/tenofovir disoproxil fumarate;   Drug: Raltegravir;   Drug: Darunavir;   Drug: Ritonavir;   Drug: Atazanavir
20 Completed Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults
Condition: HIV Infections
Intervention: Drug: Structured treatment interruption

   Previous Page Studies Shown (1-20) Next Page (21-27) Show next page of results    Last Page
Indicates status has not been verified in more than two years